UCB to acquire Candid Therapeutics for up to $2.2 billion

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Capstone Copper Q1 2026 slides: record EBITDA despite strike impact Hisse Senetleri 0 1
A US Attorney Pirro says Fed IG’s findings will dictate future of her Powell probe Hisse Senetleri 0 1
A Iran reportedly reviews US response to 14-point proposal via Pakistan Hisse Senetleri 0 1
A UCB to acquire Candid Therapeutics for up to $2.2 billion Hisse Senetleri 0 1
A Merz says US remains key NATO partner despite troop reduction plans Hisse Senetleri 0 1
A Nvidia’s pivot to physical AI ignites rally across Asian supply chain Hisse Senetleri 0 1
A UCB to acquire Neurona Therapeutics for up to $1.15 billion Hisse Senetleri 0 12
A Jefferies downgrades UCB, warns of 15% Bimzelx sales hit by 2026 Hisse Senetleri 0 44

Benzer konular

Üst